1 – 2 of 2
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer : A validation study
(
- Contribution to journal › Article
-
Mark
Rivaroxaban for stroke prevention after embolic stroke of undetermined source
(
- Contribution to journal › Article